Pregnancy has a variety of effects on maternal thyroid function. Thyroid gland enlargement is common particularly in areas of relative iodine deficiency. The renal clearance of iodine is increased in pregnancy and together with an increased volume of iodine distribution, leads to a low plasma inorganic iodine and thus increases the thyroidal iodine clearance. However, the absolute iodine uptake and hormone production rate remain unchanged.
Introduction
The observation that physiological changes in thyroid function occur in pregnancy is neither new nor is it surprising. Pregnancy goitre has been recognized for some 7000 years, and more recently a clearer understanding of its development has emerged. Four major changes ( Fig. 1 ) occur in maternal thyroid physiology during pregnancy: (i) enlargement of the thyroid, (ii) alterations in iodine handling, (iii) an increase both in thyroid hormone binding proteins and thyroid hormones and, (iv) the production of placental thyroid stimulators. In addition, recent knowledge of the physiology of the fetal thyroid permits routine screening for hypothyroidism in the newborn.
Thyroid gland enlargement
The prevalence of goitre in pregnancy varies according to the area studied and the definition of goitre. Using a standardized procedure, Crooks et al. (1964) showed that 70°/ of 184 pregnant women in Aberdeen had both visible and palpable enlargement of the thyroid compared with 37%/ of non-pregnant age-matched controls. The distribution of goitre in pregnancy was not influenced by parity, maternal age, or stage of gestation. In a comparative study (Crooks et al., 1967) with an area of high iodine intake (Iceland), there was no evidence of thyroidal enlargement in pregnancy, and goitre was equally common (20%/) in both the control and pregnant groups. There is histological evidence of large follicles and abundant colloid, suggestive of active formation and secretion of thyroid hormones (Burrow, 1975) . It has also been suggested (Tunbridge and Hall, 1975 ) that in addition to the possible stimulus of relative iodine deficiency, a proportion of the enlargement may also result from increased blood flow which is sometimes sufficient to produce a vascular bruit. The modulator of thyroid enlargement in pregnancy is not fully clear. Thyroid stimulating hormone (TSH) levels remain within the normal range for most of pregnancy (Chan, Paraskevaides and Hale, 1975) although it is possible that there is an initial TSH stimulus in early pregnancy (Malkasian and Mayberry, 1970) , sufficient to compensate for the increased requirements due to changes in hormone binding, which needs only to be temporary, as thyroxine requirements during pregnancy are unchanged (Dowling, Appleton and Nicoloff, 1967 (Burrow, 1975) . The increase in protein bound iodine (PBI), serum thyroxine (T4) to a lesser extent T3 and biologically inactive reverse T3 is principally due to an increase in circulating thyroid hormone-binding proteins, in particular thyroxine binding globulin (TBG). There is a doubling of TBG during the first trimester due to oestrogen-stimulated hepatic production. Thus the absence of a TBG and T4 rise early in pregnancy may indicate poor oestrogen production and possible fetal loss. The increase in serum T4 and T3 is maximal during the second trimester (Chan et al., 1975) and these hormones return to normal levels during the puerperium.
Thyroid hormones are highly (>99%) protein bound and it is the free unbound fraction that exerts biological activity. There is general agreement (Innerfield and Hollander, 1977) Thyroxine turnover during pregnancy has been studied following the injection of 131I-labelled T4 (Dowling et al., 1967) . As a result of a decrease in the proportion of free T4, the volume of distribution and fractional turnover are decreased slightly but, following correction for the change in surface area, the net thyroxine turnover and hormonal requirements are unchanged by pregnancy. Serum TSH levels and the response of TSH to thyrotrophinreleasing hormones (TRH) have been reported both as unaltered (Kanazawa et al., 1976) and increased during pregnancy (Burrow, 1978) . The suggestion of enhanced responsiveness of TSH to TRH is also evidence against increased thyroid activity as a minimal rise in circulating thyroid hormone usually decreases responsiveness to TRH.
Placental thyroid stimulators
Three glycoprotein thyroid stimulators have been identified in the normal placenta, namely chorionic gonadotrophin (HCG), human chorionic thyrotrophin (HCT) and human molar thyrotrophin (HMT, the last so called because it is produced in large amounts by hydatidiform moles and choriocarcinoma). HCT is similar in molecular size to TSH and has a short duration of action (peak 3 hr). Its content in normal placenta is usually small, of the order of 10 mu. per placenta (Kenimer, Hershman and Higgins, 1975) . HMT, on the other hand, is of larger molecular size with a longer duration of action and it has been suggested that it may act as a precursor for HCT (Tunbridge and Hall, 1975) .
HCG is, in addition, a weak thyroid stimulator, on a molecular basis containing 1/4000 the thyrotrophic activity of pituitary TSH, and there is some evidence that HMT may in fact be HCG (Kenimer et al., 1975) . In normal pregnancy there is probably sufficient HCG produced to stimulate the maternal thyroid gland during the first trimester. HCT is also present from early pregnancy but unlike HCG its concentration rises progressively throughout pregnancy (Kanazawa et al., 1976) , which would lead to progressive thyroidal enlargement if it were the placental thyrotrophin.
Fetal thyroid function
The fetal hypothalamic-pituitary-thyroidal system develops and functions autonomously. The transplacental passage of T4 and T3 is minimal both in animals and man (Fisher et al., 1977) . There is no correlation between maternal and fetal concentrations of T4, T3 or TSH at any time during gestation despite a concentration gradient. Furthermore, only minimal proportions of T4, or radioiodine-labelled T4, given to mothers before labour or therapeutic abortion have been detected in the fetus. Animal studies support this conclusion, but biologically active thyroid hormone analogues may cross the placenta in some species (Burrow, 1978) .
The fetal thyroid does not secrete thyroid hormone until the end of the first trimester and its development proceeds in the absence of TSH. There is an abrupt rise in fetal TSH concentrations between 18 and 24 weeks correlated temporarily with histological maturation of the hypothalmic-pituitary portal vascular system, which results in a marked increase in thyroidal production of T4 and T3. The concentration of T4, especially free T4 (as fetal TBG concentration does not increase), rises slowly after 30 weeks to that of the mother at term, whereas the elevated fetal TSH levels decline somewhat towards term (Fisher et al., 1977) .
The peripheral de-iodination of T4 is the major source of production ofT3 and almost exclusively the source of reverse T3. In the fetus, the peripheral de-iodination of thyroxine favours the production of biologically inactive reverse T3 at the expense of active T3; thus cord blood T3 concentration is approximately one fifth that of maternal (Chopra, Sack and Fisher, 1975) .
During the neonatal period there is a marked increase in serum TSH, in part a response to neonatal cooling, reaching a peak at 30 min. Serum T3 also increases, reaching an early peak at 2 hr and a second peak coincidental with the T4 and free T4 peak at 24 hr. This period of neonatal thyroid hyperactivity is transient, falling gradually over 2 to 3 days for TSH and 2 to 3 weeks for the thyroid hormones. Reverse T3 levels do not peak and return to adult range within 10 to 14 days suggesting maturation of the peripheral enzymatic pathway of thyroxine metabolism. It is now possible to recommend screening of the newborn for hypothyroidism, based on T4 or TSH, or preferably both, on either cord blood or heel prick 3 to 5 days post partum (Dussault et al., 1975) . The incidence of neonatal hypothyroidism varies from 1/4000 in a number of European countries to 1/7000 in Quebec.
